ArticleAnnals of intensive care2026
High-frequency oscillation improves mucus clearance and airway resistance in mechanically ventilated patients: a randomized clinical trial.
Article in Annals of intensive care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mechanical ventilation is associated with both impaired ciliary function and a weakened cough, which further impair secretion clearance. Continuous high-frequency oscillation (CHFO) is a promising technique to reduce respiratory muscle loading and facilitate secretion clearance in mechanically ventilated patients. The aim of this study was to assess the effect of CHFO on airway resistance (Raw). Methods: This is a prospective, randomized controlled trial conducted in a 60-bed ICU between April 2023 and March 2024. Mechanically ventilated patients with excessive airway secretions (defined as the sputum volume exceeding 150 ml within the past 24 hours) were randomly assigned to either receive CHFO for 10 minutes followed by secretion aspiration (CHFO group), or to undergo secretion aspiration alone (control group). Throughout the study, only the study intervention and necessary suctioning were performed, and patient positioning and ventilator settings were kept constant. Arterial blood gases, respiratory mechanics, and the percentage of dorsal lung ventilation (assessed by electrical impedance tomography) were measured in both groups at four timepoints: pre-intervention (baseline), immediately post-intervention (T0), one-hour post-intervention (T1), and three-hours post-intervention (T3). The primary outcome was the change in Raw from baseline at each time point (ΔRaw: R Results: 46 patients, with a median sputum volume of 160 ml over the last 24 hours, were enrolled. Baseline characteristics were well-balanced in the two groups. CHFO group showed a significantly larger decrease in Raw compared to control group at T1 (CHFO: -2.4 ± 1.8 vs. control: -0.1 ± 1.6 cmH₂O/L·s, p < 0.001) and T3 (CHFO: -1.8 ± 2.4 vs. control: -0.5 ± 1.9 cmH₂O/L·s, p < 0.05). Increase in Crs from baseline was greater in the CHFO group than control group at T1 (CHFO: 4.9 ± 8.8 vs. control: 0.3 ± 4.2 ml/cmH Conclusions: In mechanically ventilated patients with excessive airway secretions, the reduction in Raw from baseline was significantly greater in the CHFO group than control group at one-hour and three-hour post-intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.